Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid ...

Blood tests play a vital role in the management of chronic diseases by providing critical data on disease progression and ...

Munich, Germany, October 1, 2024 – (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the ...

Concerns have been raised after the NHS spending watchdog has provisionally rejected a new treatment for women with advanced ...

Tamura noted that physicians sometimes recommend dialysis because they want to offer patients hope or because the downsides of the treatment haven't always been clear. But the study indicates ...

In participants with impaired kidney function (eGFR < 60), semaglutide was linked to a 31% reduction ... benefits of semaglutide and underscore its important role as a treatment option in the ...

The sBLA is supported by results from the phase IIIDESTINY-Breast06 trial (NCT04494425), which showed that patients with HER2 ...

RHHBY has strengthened its pipeline with an agreement to acquire Regor's portfolio of next-generation CDK inhibitors for the treatment of breast cancer.

AstraZeneca and Daiichi Sankyo announced that their drug Enhertu (trastuzumab deruxtecan) has been granted Priority Review by the US FDA for trea ...

Bispecific antibodies (bsAbs) are engineered to target 2 different epitopes simultaneously. About 75% of the 16 clinically ...